The mean time to development of MID after receiving asparaginase was 2.56 days, which was comparable to Pollock et al. [27] who found that mean glucose levels peaked 3 days following administration of PEG-asparaginase during the induction phase of treatment in their cohort of children with ALL. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.